Precocious Puberty
What's New
Last Posted: Jan 13, 2025
- Novel MKRN3 gene mutation associated with central precocious puberty in a Chinese child: a case report.
Jingna Wang, et al. Frontiers in endocrinology 2025 0 1491664 - A novel ARCN1 splice-site variant in a Chinese girl with central precocious puberty, intrauterine growth restriction, microcephaly, and microretrognathia.
Guoying Chang, et al. BMC pediatrics 2024 0 (1) 838 - Genetic Investigation of Regulatory Regions of MKRN3 and DLK1 Genes in Children with Central Precocious Puberty.
Maiara Piovesan, et al. Hormone research in paediatrics 2024 0 1-13 - Genetic Polymorphisms of Prokineticins and Prokineticin Receptors Associated with Human Disease.
Roberta Lattanzi, et al. Life (Basel, Switzerland) 2024 0 (10) - The rs6576457 G?>?A variant in the MKRN3 gene promoter significantly increases the risk of central precocious puberty and lung cancer in Hubei Chinese population.
Feng Wu, et al. Human molecular genetics 2024 0 - [Clinical and genetic analysis of three children with Legius syndrome due to variants of SPRED1 gene].
Xi Wang, et al. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2024 0 (8) 941-946 - Understanding the genetic complexity of puberty timing across the allele frequency spectrum.
Katherine A Kentistou, et al. Nature genetics 2024 0 - The Genetic Etiology is a Relevant Cause of Central Precocious Puberty.
Ana Pinheiro Machado Canton, et al. European journal of endocrinology 2024 0 - Association of obesity and menarche SNPs and interaction with environmental factors on precocious puberty.
Peng Xue, et al. Pediatric research 2024 0 - Dual rare genetic diseases in five pediatric patients: insights from next-generation diagnostic methods.
Yupeng Liu, et al. Orphanet journal of rare diseases 2024 0 (1) 159
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: